164 related articles for article (PubMed ID: 31783120)
21. Escalating dose-multiple binge methamphetamine treatment elicits neurotoxicity, altering gut microbiota and fecal metabolites in mice.
Chen LJ; Zhi X; Zhang KK; Wang LB; Li JH; Liu JL; Xu LL; Yoshida JS; Xie XL; Wang Q
Food Chem Toxicol; 2021 Feb; 148():111946. PubMed ID: 33359793
[TBL] [Abstract][Full Text] [Related]
22. Methamphetamine-induced dopaminergic neurotoxicity in mice: long-lasting sensitization to the locomotor stimulation and desensitization to the rewarding effects of methamphetamine.
Itzhak Y; Martin JL; Ali SF
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Oct; 26(6):1177-83. PubMed ID: 12452543
[TBL] [Abstract][Full Text] [Related]
23. The neurotoxin, MPP+, induces hyperphosphorylation of Tau, in the presence of alpha-Synuclein, in SH-SY5Y neuroblastoma cells.
Duka T; Sidhu A
Neurotox Res; 2006 Aug; 10(1):1-10. PubMed ID: 17000465
[TBL] [Abstract][Full Text] [Related]
24. Role of GSK3β/α-synuclein axis in methamphetamine-induced neurotoxicity in PC12 cells.
Li L; Chen S; Wang Y; Yue X; Xu J; Xie W; Qiu P; Liu C; Wang A; Wang H
Toxicol Res (Camb); 2018 Mar; 7(2):221-234. PubMed ID: 30090577
[TBL] [Abstract][Full Text] [Related]
25. Aggregation-prone A53T mutant of α-synuclein exaggerates methamphetamine neurotoxicity in SH-SY5Y cells: Protective role of cellular cholesterol.
Aoki S; Funakoshi T; Aki T; Uemura K
Toxicol Rep; 2022; 9():2020-2029. PubMed ID: 36518421
[TBL] [Abstract][Full Text] [Related]
26. Attenuation of cocaine and methamphetamine neurotoxicity by coenzyme Q10.
Klongpanichapak S; Govitrapong P; Sharma SK; Ebadi M
Neurochem Res; 2006 Mar; 31(3):303-11. PubMed ID: 16733807
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of PLCβ1 signaling pathway regulates methamphetamine self-administration and neurotoxicity in rats.
Xu X; Fan R; Ruan Y; Xu M; He J; Cao M; Li X; Zhou W; Liu Y
Food Chem Toxicol; 2021 Mar; 149():111970. PubMed ID: 33421459
[TBL] [Abstract][Full Text] [Related]
28. α-Synuclein modulates tau spreading in mouse brains.
Bassil F; Meymand ES; Brown HJ; Xu H; Cox TO; Pattabhiraman S; Maghames CM; Wu Q; Zhang B; Trojanowski JQ; Lee VM
J Exp Med; 2021 Jan; 218(1):. PubMed ID: 33091110
[TBL] [Abstract][Full Text] [Related]
29. Icariside II Attenuates Methamphetamine-Induced Neurotoxicity and Behavioral Impairments via Activating the Keap1-Nrf2 Pathway.
Huang J; Ding J; Wang Z; Li Y; He Y; Wang X; Fan H; Xie Q; Qiu P
Oxid Med Cell Longev; 2022; 2022():8400876. PubMed ID: 35387263
[TBL] [Abstract][Full Text] [Related]
30. Effects of Moderate-Intensity Interval Training on Gene Expression and Antioxidant Status in the Hippocampus of Methamphetamine-Dependent Rats.
Shafiei A; Haghighi AH; Askari R; Keyhani A; Nabavizadeh MS; Asadi-Shekaari M
Neurotox Res; 2022 Oct; 40(5):1455-1463. PubMed ID: 35781220
[TBL] [Abstract][Full Text] [Related]
31. Asiatic acid attenuates methamphetamine-induced neuroinflammation and neurotoxicity through blocking of NF-kB/STAT3/ERK and mitochondria-mediated apoptosis pathway.
Park JH; Seo YH; Jang JH; Jeong CH; Lee S; Park B
J Neuroinflammation; 2017 Dec; 14(1):240. PubMed ID: 29228978
[TBL] [Abstract][Full Text] [Related]
32. Protective and restorative effects of the traditional Chinese medicine Jitai tablet against methamphetamine-induced dopaminergic neurotoxicity.
Xu S; Tu S; Gao J; Liu J; Guo Z; Zhang J; Liu X; Liang J; Huang Y; Han M
BMC Complement Altern Med; 2018 Feb; 18(1):76. PubMed ID: 29475448
[TBL] [Abstract][Full Text] [Related]
33. Methyllycaconitine prevents methamphetamine-induced effects in mouse striatum: involvement of alpha7 nicotinic receptors.
Escubedo E; Chipana C; Pérez-Sánchez M; Camarasa J; Pubill D
J Pharmacol Exp Ther; 2005 Nov; 315(2):658-67. PubMed ID: 16076935
[TBL] [Abstract][Full Text] [Related]
34. Methamphetamine exposure upregulates the amyloid precursor protein and hyperphosphorylated tau expression: The roles of insulin signaling in SH-SY5Y cell line.
Chen L; Zhou L; Yu P; Fang F; Jiang L; Fei J; Xiao H; Wang J
J Toxicol Sci; 2019; 44(7):493-503. PubMed ID: 31270305
[TBL] [Abstract][Full Text] [Related]
35. Involvement of nicotinic receptors in methamphetamine- and MDMA-induced neurotoxicity: pharmacological implications.
Escubedo E; Camarasa J; Chipana C; García-Ratés S; Pubill D
Int Rev Neurobiol; 2009; 88():121-66. PubMed ID: 19897077
[TBL] [Abstract][Full Text] [Related]
36. Long-term changes in basal ganglia function after a neurotoxic regimen of methamphetamine.
Chapman DE; Hanson GR; Kesner RP; Keefe KA
J Pharmacol Exp Ther; 2001 Feb; 296(2):520-7. PubMed ID: 11160639
[TBL] [Abstract][Full Text] [Related]
37. Pifithrin-Alpha Reduces Methamphetamine Neurotoxicity in Cultured Dopaminergic Neurons.
Chen YH; Bae E; Chen H; Yu SJ; Harvey BK; Greig NH; Wang Y
Neurotox Res; 2019 Aug; 36(2):347-356. PubMed ID: 31069753
[TBL] [Abstract][Full Text] [Related]
38. Pα-syn* mitotoxicity is linked to MAPK activation and involves tau phosphorylation and aggregation at the mitochondria.
Grassi D; Diaz-Perez N; Volpicelli-Daley LA; Lasmézas CI
Neurobiol Dis; 2019 Apr; 124():248-262. PubMed ID: 30472299
[TBL] [Abstract][Full Text] [Related]
39. Influence of Early Life Lead (Pb) Exposure on α-Synuclein, GSK-3β and Caspase-3 Mediated Tauopathy: Implications on Alzheimer's Disease.
Bihaqi SW; Alansi B; Masoud AM; Mushtaq F; Subaiea GM; Zawia NH
Curr Alzheimer Res; 2018; 15(12):1114-1122. PubMed ID: 30068273
[TBL] [Abstract][Full Text] [Related]
40. GSK-3β dysregulation contributes to parkinson's-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and α-synuclein.
Credle JJ; George JL; Wills J; Duka V; Shah K; Lee YC; Rodriguez O; Simkins T; Winter M; Moechars D; Steckler T; Goudreau J; Finkelstein DI; Sidhu A
Cell Death Differ; 2015 May; 22(5):838-51. PubMed ID: 25394490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
